The endoscopes market in the United States is expected to reach a projected revenue of US$ 11,961.1 million by 2030. A compound annual growth rate of 4.3% is expected of the United States endoscopes market from 2024 to 2030.
In terms of revenue, U.S. accounted for 36.9% of the global endoscopes market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In North America, U.S. endoscopes market is projected to lead the regional market in terms of revenue in 2030.
Canada is the fastest growing regional market in North America and is projected to reach USD 921.8 million by 2030.
The growing preference for minimally invasive procedures across various medical specialties in the U.S., including gastroenterology, pulmonology, urology, gynecology, and otolaryngology, is driving the demand for endoscopes.
Furthermore, the rising prevalence of cancer, growing geriatric population susceptible to chronic illnesses requiring endoscopic procedures, and the increasing importance of timely disease diagnosis & early interventions are driving the demand for endoscopes.
According to the American Cancer Society, approximately 26,500 new cases of stomach cancer and around 11,130 stomach cancer-related deaths are expected to be reported in 2023. Moreover, an advanced healthcare infrastructure, high investments by market players and hospitals promoting the use of novel endoscopy equipment, and favorable reimbursement policies are factors expected to drive market growth in the U.S. For instance, in June 2021, EvoEndo raised USD 10.1 million to promote the use of unsedated transnasal for patients and physicians.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Endoscopes Market Outlook will help companies and investors design strategic landscapes.
Endoscopes was the largest segment with a revenue share of 104.58% in 2023.
Horizon Databook has segmented the U.S. endoscopes market based on endoscopes covering the revenue growth of each sub-segment from 2018 to 2030.
The growing preference for minimally invasive procedures across various medical specialties in the U.S., including gastroenterology, pulmonology, urology, gynecology, and otolaryngology, is driving the demand for endoscopes.
Furthermore, the rising prevalence of cancer, growing geriatric population susceptible to chronic illnesses requiring endoscopic procedures, and the increasing importance of timely disease diagnosis & early interventions are driving the demand for endoscopes.
According to the American Cancer Society, approximately 26,500 new cases of stomach cancer and around 11,130 stomach cancer-related deaths are expected to be reported in 2023. Moreover, an advanced healthcare infrastructure, high investments by market players and hospitals promoting the use of novel endoscopy equipment, and favorable reimbursement policies are factors expected to drive market growth in the U.S. For instance, in June 2021, EvoEndo raised USD 10.1 million to promote the use of unsedated transnasal for patients and physicians.
U.S. Endoscopes Market Product Outlook (Revenue, USD Million , 2018-2030)
Endoscopes
Reasons to subscribe to Endoscopes Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Endoscopes Market Outlook databook
Our clientele includes a mix of Endoscopes Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Endoscopes Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Endoscopes Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.